Gam Holding Ag Ultragenyx Pharmaceutical Inc. Transaction History

Gam Holding Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $3.64 Million - $4.57 Million	-50,700 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$48.54 - $85.31 $48,540 - $85,310	1,000 Added 2.01%	50,700 $3.9 Million
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $1.26 Million - $1.66 Million	-28,400 Reduced 36.36%	49,700 $2.53 Million
Q2 2017 Aug 07, 2017	BUY	N/A	78,100	78,100 $4.85 Million

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.22B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.